Mese: Ottobre 2024

Mimesis recently participated in the XV Forum della Borsa della Ricerca an annual national event that brings together a diverse array of stakeholders, including businesses, investors, universities, spin-offs, startups, research groups, and centers. This year’s forum, co-organized with the University of Catania and the Sicilian Region, was held at the historic Monastero dei Benedettini from October 21 to 23, 2024. A standout moment for Mimesis was the pitch presentation delivered by Martina Di Salvatore. During this session, she effectively showcased our innovative solutions in computational medicine, demonstrating how Mimesis leverages advanced computational models to simulate immune responses and address various health challenges. The unique format of the forum included One-to-One meetings that allowed delegates to connect based on mutual interests and needs. Two weeks before the event, participants could access a preview of all attendees and schedule meetings accordingly. This personalized approach resulted in numerous productive encounters with a wide array of companies, fostering valuable discussions on potential partnerships and collaborations. In addition to Mimesis’s contributions, the forum featured an array of engaging sessions and workshops, including a plenary session with institutional greetings from notable figures such as Francesco Priolo, Rector of the University of Catania, and Edmondo Tamajo, Regional Councillor for Productive Activities. The forum also hosted specialized events like the CrossRoads NODES and CrossRoads Samothrace, focusing on sectors such as agroindustry and life sciences, as well as various workshops dedicated to quantum technologies and innovative business development. The final day included a Pitch Session, where startups and spin-offs had the opportunity to present their ideas to a broader audience, culminating in the prestigious BdR Awards. Mimesis’s active engagement in this forum underscores our commitment to fostering innovation and collaboration in the realm of computational medicine. As we look forward to the future, Mimesis remains dedicated to driving advancements in healthcare through cutting-edge technology and strategic partnerships, contributing to the vibrant ecosystem of research and development in Sicily.

Catania, October 24, 2024 – Mimesis proudly participated in a significant event organized by the Observatory on Trends and Applications of Supercomputing. This gathering aimed to explore the transformative potential of supercomputing and its implications for the healthcare sector, particularly in computational medicine. Representing Mimesis, Martina Di Salvatore emphasized the critical role that advanced computational resources play in the field of in silico medicine. Mimesis, as a spin-off of the University of Catania, is dedicated to offering innovative solutions for the biomedical and pharmaceutical industries. Through the use of computational models, the company simulates the immune system’s behavior, enabling accurate responses in the context of various health challenges and therapies. Professor Francesco Pappalardo, a key figure in the company and co-leader of Spoke 8 ‘In Silico Medicine and Omics Data’ at the ICSC, highlighted how “in silico medicine is revolutionizing the research and development of new treatments, reducing drug development times and improving the precision of therapeutic interventions.” The event also featured the participation of other promising spin-offs from the University of Catania, as well as notable institutions like Ospedale Cannizzaro, showcasing the vibrant entrepreneurial ecosystem in the region. These organizations are leveraging advanced technologies to contribute to various sectors, highlighting the synergy between academic research and industry innovation. The gathering underscored the growing demand for supercomputing services, with projections indicating a significant increase in need by 2030. This surge presents substantial opportunities for companies that can harness advanced computational tools to drive innovation and enhance healthcare outcomes. As Mimesis continues to push the boundaries of computational medicine, it plays a vital role in shaping the future of healthcare in the region. The company is committed to advancing personalized medicine, aiming to streamline drug development processes and improve the precision of therapeutic interventions, ultimately benefiting patients and healthcare providers alike.